Averill Master Fund, Ltd.
Director at Veradermics; Director at Benitec Biopharma.
- Rank
- 561st of 813
- Companies held
- 2
- Largest holding
- MANE, 89.0% of total
- Latest SEC filing
- Aug 20, 2026
What the $137M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Veradermics MANE Common stock, par value $0.00001 per share | Indirectly (see filing footnote) | 612,033 | $124.39 | $76.1M | 55.4% | Form 4, Aug 20, 2026 |
| Veradermics MANE Common stock, par value $0.00001 per share | I | 370,859 | $124.39 | $46.1M | 33.6% | Form 3, Feb 4, 2026 |
| Benitec Biopharma BNTC Common stock, par value $0.0001 per share | Indirectly (see filing footnote) | 1,848,156 | $8.14 | $15.0M | 11.0% | Form 4, Dec 29, 2025 |
Share counts are the amounts Averill Master Fund, Ltd. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Sold | MANE | 690,601 | $107.25 | $74.1M | View |
| Aug 19, 2026 | Sold | MANE | 59,399 | $107.25 | $6.4M | View |
| Dec 29, 2025 | Bought | BNTC | 65,800 | $13.44 | $884K | View |
| Dec 29, 2025 | Bought | BNTC | 11,587 | $13.44 | $156K | View |
| Dec 26, 2025 | Bought | BNTC | 14,320 | $13.10 | $188K | View |
| Dec 26, 2025 | Bought | BNTC | 2,516 | $13.10 | $33K | View |
| Dec 23, 2025 | Bought | BNTC | 7,400 | $12.85 | $95K | View |
| Dec 23, 2025 | Bought | BNTC | 42,600 | $12.85 | $547K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 558 | Essex Equity Holdings, LLC Insider, Reservoir Media | $139M |
| 559 | 325 Capital GP, LLC Insider, American Public Education | $138M |
| 560 | Suntx Capital Partners II Dutch Investors LP Director, Construction Partners | $138M |
| 561 | Averill Master Fund, Ltd. Director, Veradermics | $137M |
| 562 | Sequoia Capital U.s. Growth Vii Principals Fund, L.P. 10% owner, DoorDash | $136M |
| 563 | Sequoia Capital U.s. Venture Fund Xiv, L.P. 10% owner, DoorDash | $136M |
| 564 | Sequoia Capital Global Growth Fund III - U.S./India Annex Fund, L.P. 10% owner, DoorDash | $136M |
Other Veradermics insiders
All MANE insiders- John W. Childs$261MDirector. #539 overall
- Vlad Coric$88.3MDirector. #1155 overall
- Timothy August Durso$24.2MChief Technical Officer. #4480 overall
- Reid Alexander Waldman$21.2MChief Executive Officer. #4956 overall
Questions
How much stock does Averill Master Fund, Ltd. own?
Averill Master Fund, Ltd. holds $137,305,926 in listed stock based on SEC filings and current prices, mostly Veradermics (MANE). That ranks 561st on the Stock Rich List.
Is this Averill Master Fund, Ltd.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Averill Master Fund, Ltd. last buy or sell stock?
The most recent open-market trade on file is a sale of 690,601 MANE shares on Aug 19, 2026 at $107.25.
Files jointly with SEC filer 1869640.